Meta-analysis and adjusted indirect comparison of direct oral anticoagulants in prevention of acute limb ischemia in patients with atrial fibrillation.

CONCLUSIONS: Significant differences in prevention of acute limb ischemia may exist between oral anticoagulant agents in patients with atrial fibrillation. Rivaroxaban lowers the risk of limb embolism versus warfarin, apixaban and dabigatran. PMID: 26949899 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26949899?dopt=Abstract

Source: Current Medical Research and Opinion - March 9, 2016 Category: Research Tags: Curr Med Res Opin Source Type: research